Japan’s first atopy visualization app from Chiba has been selected as one of the 5 finalists of “CHIBA Busicon 2022” sponsored by Chiba Prefecture!
Japan’s largest application for atopic patients “Atopiyo” ~ January 19th (Thursday) to Makuhari Messe ~
Atopiyo LLC (Location: Ichikawa City, Chiba Prefecture,
Representative: Ryotaro Ako) will be held at Makuhari Messe on January 19, 2023 (Thursday). We are pleased to announce that Ryotaro Ako will be on stage as a developer of the anonymous image sharing application “Atopiyo” for people with atopy and will announce the concept of Atopiyo.
Atopiyo URL: https://www.atopiyo.com
Atopiyo developer – Chiba Prefecture CHIBA Busicon 2022
Name: “Chiba Entrepreneur Exchange Meeting in Makuhari Messe” CHIBA Busicon 2022 Final Judging Committee sponsored by Chiba Prefecture Date: Thursday, January 19, 2023 11:00 – 17:00
Venue: Makuhari Messe International Conference Hall (2-1 Nakase, Mihama-ku, Chiba-shi, Chiba) 2nd floor convention hall A/B, 3rd floor conference room
Participation fee: Free (registration required) * Pre-registration or registration on the day at the venue
[What is CHIBA Busicon 2022]
We will hold a business plan competition to actively support entrepreneurship from Chiba with new ideas and new methods that meet the needs of Chiba Prefecture. This competition is based on the premise of starting a business in Chiba Prefecture, soliciting business ideas and business plans that will lead to problem solving in Chiba Prefecture, and selecting excellent business ideas and business plans, awarding and supporting them. , to revitalize the economy of Chiba Prefecture and foster entrepreneurial momentum in Chiba Prefecture.
[What is Atopiyo]
Atopiyo aims to support the early recovery of people suffering from atopy, and by posting not only text but also “images”, it is possible to anonymously record and share skin symptoms peculiar to atopy in Japan. It is an application (surveyed by Atopiyo in July 2018. Researched App Store and Google Play). After Ryotaro Ako, a former atopy patient, released it from the App Store in July 2018, he won nine awards, including the Minister of Health, Labor and Welfare Award at the 10th Healthy Life Expectancy Awards sponsored by the Ministry of Health, Labor and Welfare. As of December 2022, it has grown into Japan’s largest app for atopic patients, with 22,000 downloads and 51,000 posted images (9,000 of which are open to the public). In addition, the average rating of the app is 4.4 (out of 5), and it is highly supported by users.
App Store URL: https://goo.gl/xRJeyX
What is Atopiyo-Chiba CHIBA Busicon 2022
Former atopy. programmer. Master of Engineering. CPA.
Based on his experiences with three allergic diseases, atopy, asthma, and rhinitis, he has been involved in volunteer activities at patient associations. Hearing with atopy, the opinion of Akiko Ako, a pharmacist, and the guidance and supervision of a programmer, he developed this application himself.
・3rd place in the 3rd Health and Medical Venture Awards ・Plamed Award (sponsored by: Keio University School of Medicine, supported by: Ministry of Health, Labor and Welfare, etc.)
・Received the 13th Kids Design Award (Organizer: Kids Design Association, Support: Cabinet Office, etc.)
・Japan Healthcare Business Contest 2020 Excellence Award/Special Award (Sponsored by Ministry of Economy, Trade and Industry)
・Inno vation 2020 Generation Award Corporate Special Award (sponsored by Ministry of Internal Affairs and Communications)
・ Let’s extend the 10th healthy life expectancy! Award Minister of Health, Labor and Welfare Award (sponsored by Ministry of Health, Labor and Welfare)
Company name: Atopiyo LLC / Atopiyo LLC
Location: Ichikawa City, Chiba Prefecture
Representative: Ryotaro Ako / Ryotaro AKO
Date of establishment: March 15, 2021
Business: Development of software in the field of atopic dermatitis, information processing and information provision services, support for surveys, research, product development, and disease awareness Company URL: https://www.atopiyo.com
TEL: 070-8932-1623 / 050-3552-5789
Details about this release: